WO2011056545A3 - Liquides ioniques antimicrobiens - Google Patents

Liquides ioniques antimicrobiens Download PDF

Info

Publication number
WO2011056545A3
WO2011056545A3 PCT/US2010/054048 US2010054048W WO2011056545A3 WO 2011056545 A3 WO2011056545 A3 WO 2011056545A3 US 2010054048 W US2010054048 W US 2010054048W WO 2011056545 A3 WO2011056545 A3 WO 2011056545A3
Authority
WO
WIPO (PCT)
Prior art keywords
ionic liquids
antimicrobial
antimicrobial ionic
species
pared
Prior art date
Application number
PCT/US2010/054048
Other languages
English (en)
Other versions
WO2011056545A2 (fr
Inventor
Mark W. Grinstaff
Michel Wathier
George A. O'toole
Original Assignee
Trustees Of Boston University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trustees Of Boston University filed Critical Trustees Of Boston University
Publication of WO2011056545A2 publication Critical patent/WO2011056545A2/fr
Publication of WO2011056545A3 publication Critical patent/WO2011056545A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Certains aspects de la présente invention concernent des compositions, des préparations, et l'utilisation de liquides ioniques comme agents antimicrobiens (par ex. comme agents antibactériens et/ou antifongiques). Dans certains modes de réalisation, les liquides ioniques peuvent être associés à une ou plusieurs espèce(s) à charge unique ou avec une ou plusieurs espèce(s) à plusieurs charges.
PCT/US2010/054048 2009-10-26 2010-10-26 Liquides ioniques antimicrobiens WO2011056545A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25495709P 2009-10-26 2009-10-26
US61/254,957 2009-10-26

Publications (2)

Publication Number Publication Date
WO2011056545A2 WO2011056545A2 (fr) 2011-05-12
WO2011056545A3 true WO2011056545A3 (fr) 2011-09-22

Family

ID=43970658

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/054048 WO2011056545A2 (fr) 2009-10-26 2010-10-26 Liquides ioniques antimicrobiens

Country Status (1)

Country Link
WO (1) WO2011056545A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3062819B1 (fr) 2013-11-03 2021-12-22 The Regents of The University of California Liquides ioniques pour administration transdermique de médicaments
CN109789216B (zh) 2016-08-29 2023-05-23 加利福尼亚大学董事会 基于离子物种的皮肤治疗局部制剂
DK3528856T3 (da) 2016-10-18 2023-10-16 Univ Marquette Kompositmaterialer, der indeholder strukturelle polymerer og fotoreaktive nitrogenoxidfrigørende midler og anvendelser deraf til sårbandager
US10828265B2 (en) 2016-12-09 2020-11-10 The Regents Of The University Of California Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery
EP3739006A1 (fr) 2019-05-15 2020-11-18 The Hong Kong University of Science and Technology Revêtement à base de liquide ionique et procédé de fabrication d'articles ainsi revêtus
US11781106B1 (en) * 2021-03-01 2023-10-10 United States Of America As Represented By The Secretary Of The Air Force Intracellular non-genetic modification of microorganisms using protein ionic liquids
CN117717892B (zh) * 2024-02-08 2024-04-30 四川益能康生环保科技有限公司 一种用于吸收二氧化硫的复合型脱硫剂及其制备工艺

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077519A1 (en) * 2002-06-28 2004-04-22 The Procter & Gamble Co. Ionic liquid based products and method of using the same
US20070167332A1 (en) * 1999-09-07 2007-07-19 Akzo Nobel Surface Chemistry Llc Quaternary ammonium salts as thickening agents for aqueous systems
US20070225191A1 (en) * 2006-03-27 2007-09-27 The Procter & Gamble Company Methods for modifying bioplymers in ionic liquids
US20080070966A1 (en) * 2006-06-14 2008-03-20 Elder Stewart T Anti-microbial compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070167332A1 (en) * 1999-09-07 2007-07-19 Akzo Nobel Surface Chemistry Llc Quaternary ammonium salts as thickening agents for aqueous systems
US20040077519A1 (en) * 2002-06-28 2004-04-22 The Procter & Gamble Co. Ionic liquid based products and method of using the same
US20070225191A1 (en) * 2006-03-27 2007-09-27 The Procter & Gamble Company Methods for modifying bioplymers in ionic liquids
US20080070966A1 (en) * 2006-06-14 2008-03-20 Elder Stewart T Anti-microbial compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KATHRYN M. DOCHERTY ET AL.: "Toxicity and antimicrobial activity of imidazolium and pyridinium ionic liquids", GREEN CHEMISTRY, vol. 7, 2005, pages 185 - 189 *

Also Published As

Publication number Publication date
WO2011056545A2 (fr) 2011-05-12

Similar Documents

Publication Publication Date Title
WO2011056545A3 (fr) Liquides ioniques antimicrobiens
MX2009012461A (es) Composiciones agroquimicas de acido bioactivo y usos de las mismas.
IL249141B (en) Preparations for the treatment of parasites containing a large number of active factors, their methods and uses
MX363004B (es) Formulaciones desinfectantes tópicas y usos de las mismas.
MX2014006414A (es) Dispositivos de cateter y tecnicas.
GEP20156376B (en) Solid herbicide compositions with built-in adjuvant
WO2008104310A3 (fr) Compositions antimicrobiennes
IL215592A (en) Compounds, preparations containing them and their uses in the treatment or prevention of conditions in the eyes
HK1180237A1 (zh) 抗微生物肽，組合物和使用方法
WO2011091322A3 (fr) Agents antimicrobiens et procédés d'utilisation associés
EP2217614A4 (fr) Compositions et formulations antimicrobiennes et leurs utilisations
MY173847A (en) Disinfectant compositions and uses thereof
WO2011038316A3 (fr) Compositions de dibromomalonamide et leur utilisation comme biocides
WO2011150457A3 (fr) Inhibiteurs de la prostaglandine d2 synthase hématopoïétique
WO2012148720A3 (fr) Peptides antimicrobiennes et leurs procédés d'utilisation
EP2312952A4 (fr) Composition antimicrobienne
WO2011094504A3 (fr) Compositions, procédés et dispositifs d'irrigation de sinus antimicrobienne
WO2011119954A3 (fr) Composites antimicrobiens à base de silice
MX2015008373A (es) Peptidos antimicrobianos, composiciones que los comprende y usos.
WO2014186344A3 (fr) Méthodes et agents permettant de traiter la forme tyrosinase positive de l'albinisme
MX342592B (es) Composiciones de dibromomalonamida y sus usos como biocidas.
WO2010127335A3 (fr) Composition de pyrithione de zinc antimicrobienne et procédé
PH12016501448A1 (en) Antifungal composition
WO2013158773A3 (fr) Peptides antimicrobiens à base d'arnase 7
MX342968B (es) Composiciones de dibromomalonamida y su uso como biocida.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10828844

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10828844

Country of ref document: EP

Kind code of ref document: A2